WPG Advisers’s Cidara Therapeutics CDTX Stock Holding History

WPG Advisers’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-48	Closed	-$10.6K	–	1489
2025 Q4	$10.6K	Sell	48 -81	-63%	-$13.1K	0.01%	684
2025 Q3	$12.4K	Buy	+129	New	+$8.23K	0.01%	636

WPG Advisers's CDTX Position: Q1 2026 in Review

WPG Advisers sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 48 shares — an estimated $10.6K sold.

WPG Advisers first reported a position in CDTX in Q3 2025 and held it in 2 quarters. The position peaked at $12.4K in Q3 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

WPG Advisers reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
WPG Advisers sold 48 Cidara Therapeutics shares in Q1 2026, an estimated $10.6K.
WPG Advisers first reported a position in Cidara Therapeutics in Q3 2025 and held it in 2 quarters.
WPG Advisers's Cidara Therapeutics position peaked at $12.4K in Q3 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on WPG Advisers's 13F filing for Q1 2026, filed 30 Apr 2026.